Industry & Policy News

[Science] Artificial intelligence tools promise to help researchers digest scholarly literature in new ways, but technical and legal barriers may hinder widespread use.

[BioStem Technologies, Inc.] BioStem Technologies Inc. announced that the Centers for Medicare and Medicaid Services has published a new Q code for VENDAJE AC® pursuant to its application for Healthcare Common Procedure Coding System “Q” codes. VENDAJE AC is a human connective tissue matrix comprised of dehydrated amniotic/chorionic tissue processed using BioStem’s proprietary BioREtain® process.

[BeiGene, Ltd.] BeiGene, Ltd. and Ensem Therapeutics, Inc. announced an agreement for BeiGene to acquire an exclusive global license to an Investigational New Drug application-ready oral cyclin-dependent kinase 2 (CDK2) inhibitor.

[Nature] More than 50,000 human-brain-imaging articles have been published since MRI came on the scene in the 1990s. But of those, less than 0.5% consider health factors specific to women.

[The New York Times] Shortly after a baby is born, doctors clamp the umbilical cord linking the infant to the placenta, which is still inside the mother’s uterus, and then cut it. New research shows that if doctors wait at least two minutes after the birth to clamp the cord, they significantly improve in-hospital survival rates for premature infants.

[UC San Diego] Two researchers at the University of California San Diego received close to $10 million in grants from the California Institute of Regenerative Medicine, the agency announced.